Neucure Lifesciences Private Limited
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.mg)
Glimzab MV3 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimzab MV3 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimzab MV3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimzab MV3 Tablet SR.
Glimzab MV3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimzab MV3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimzab MV3 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly.
Glimzab MV3 Tablet SR is a combination medication containing glimepiride, metformin, and voglibose. It's used to treat type 2 diabetes mellitus (DM). It helps lower blood glucose levels by improving insulin release, reducing glucose production in the liver, and inhibiting alpha-glucosidase activity which impacts postprandial glucose levels. This combination is not suitable for type 1 DM treatment.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory tract infections. If you experience any unusual symptoms, consult your doctor or pharmacist immediately.
Before taking Glimzab MV3 Tablet SR, inform your doctor if you have a known allergy to any component or excipient. It's also recommended to avoid its use in patients with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, mixing Glimzab MV3 Tablet SR with alcohol is not advisable. This combination can lead to hypoglycemia and increase the risk of lactic acidosis.
Yes, Glimzab MV3 Tablet SR may cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This risk increases if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medications simultaneously. Regular blood sugar monitoring is essential to manage this effect. Keep glucose tablets, honey, or fruit juice with you at all times.
Store Glimzab MV3 Tablet SR in its original package, tightly closed. Refer to the label or packaging information for specific storage recommendations. Always dispose of unused medication safely, ensuring it's inaccessible to children, pets, and other individuals.